Jump Financial LLC Purchases Shares of 77,162 Option Care Health, Inc. (NASDAQ:OPCH)

Jump Financial LLC acquired a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 77,162 shares of the company’s stock, valued at approximately $1,790,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in OPCH. Cornerstone Investment Partners LLC grew its stake in shares of Option Care Health by 3.6% during the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company’s stock worth $221,000 after purchasing an additional 333 shares during the period. UMB Bank n.a. grew its position in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after buying an additional 346 shares during the period. Assetmark Inc. increased its stake in shares of Option Care Health by 2.0% in the 4th quarter. Assetmark Inc. now owns 24,976 shares of the company’s stock valued at $579,000 after acquiring an additional 487 shares during the last quarter. Pacer Advisors Inc. raised its position in shares of Option Care Health by 2.2% in the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock valued at $591,000 after acquiring an additional 537 shares during the period. Finally, Sheets Smith Wealth Management boosted its stake in Option Care Health by 2.4% during the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock worth $553,000 after acquiring an additional 550 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Insider Activity at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is owned by insiders.

Option Care Health Price Performance

Shares of OPCH opened at $32.09 on Friday. The company has a 50 day moving average of $33.33 and a 200-day moving average of $28.66. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $5.27 billion, a P/E ratio of 26.96, a P/E/G ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on OPCH shares. JPMorgan Chase & Co. increased their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and boosted their target price for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and raised their price target for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Barrington Research increased their target price on Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $33.00.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.